Ansana provides innovative surgical instrument reprocessing technology for healthcare markets in the US and Europe, self-described as setting a new standard for quality, sustainability, efficiency, and service.

Ansana

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STERIS plc

CMR Surgical is a British medical device company that produces the Versius Surgical Robotic System, a robot-assisted surgery system designed to make minimal access surgery more accessible to patients. The company is dedicated to transforming surgery for millions of people by empowering surgeons and delivering high-quality surgical care worldwide.

Luke Hares

Mark Slack

Martin Frost

CMR Surgical Ltd

HubSpot, Inc. provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific. The company's CRM platform includes marketing, sales, service, and content management systems, as well as integrated applications, such as search engine optimization, blogging, website content management, messaging, chatbots, social media, marketing automation, email, predictive lead scoring, sales productivity, knowledge base, commerce, conversation routing, video hosting, ticketing and helpdesk tools, customer NPS surveys, analytics, and reporting. It also offers professional services to educate and train customers on how to leverage its CRM platform, as well as phone and/or email and chat-based support services. The company serves mid-market business-to-business companies. HubSpot, Inc. was incorporated in 2005 and is headquartered in Cambridge, Massachusetts.

Metric
Company Name	Ansana	STERIS plc	CMR Surgical Ltd	HubSpot, Inc.
Symbol		STE		HUBS
MSH ID	HEALTH:ANSANA	COM:STERIS	COM:CMRSURGICAL	COM:HUBSPOT
Market	PRIVATE	STOCKS	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Technology
Industry	Medical Devices	Medical - Devices	Medical devices & equipment	Software - Application
Country	US	IE		US
Stage	Seed Round		Series D
Employee Count		18K	501	7.83K
Website	ansana.health	steris.com	cmrsurgical.com	hubspot.com
LinkedIn				hubspot
Founders

Metric
Market Cap		21.29B		25.09B
Enterprise Value
Monthly Web Traffic	1.39K		6.91K	61.43M
Web Traffic Growth			-0.24	-0.04
Valuation
Raised Capital	933.17K		163.95M

Metric
Revenue	5.14B	2.17B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.23B	1.82B
EBITDA	1.47B	15.62M
Operating Income	905.42M	-208.06M
Net Income	378.24M	-176.29M
EPS	3.83	-3.53
Diluted EPS	3.81	-3.53
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.45	0.85
Operating Profit Margin	0.16	-0.04
EBITDA Margin	0.29	0.01
Net Profit Margin	0.10	-0.01
Return on Equity	0.09	-0.02
Return on Assets	0.05	-0.01
Return on Capital Employed	0.10	-0.05

ANSA

HEALTH:ANSANA

Ansana

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	39.67	-169.71
P/B Ratio	3.52	25.51
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.48	14.45
EV Multiple	20.35	7.52K

Metric
Days Sales Outstanding	65.65	37.67
Days Payables Outstanding	36.32	18.20
Days Inventory Outstanding	102.40	104.93
Operating Cycle	167.47	154.60
Cash Conversion Cycle	134.35	144.98
Asset Turnover	0.54	0.72

Metric
Operating Cash Flow	973.27M	350.97M
Free Cash Flow	612.95M	250.72M
Cash Flow to Debt	0.45	0.81
Operating Cash Flow/Sales	0.18	0.18
Free Cash Flow Yield	0.02	0.01

Metric
Cash & Equivalents	207.02M	387.99M
Accounts Receivable	-128.07M	-57.62M
Inventory	674.53M	99.33M
Goodwill	4.07B	173.76M
Debt to Capitalization	0.35	0.37
Debt to Assets	0.30	0.28
Current Ratio	2.49	2.35
Quick Ratio	2.36	1.96

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.19
R&D to Revenue	0.02	0.28
SG&A to Revenue		0.11